McKesson stock slides 7.16% and underperforms competitors
Updated
Updated · MarketWatch · May 6
McKesson stock slides 7.16% and underperforms competitors
9 articles · Updated · MarketWatch · May 6
Shares closed at $743.67 on Wednesday, their sixth straight daily loss, while the S&P 500 rose 1.46% and the Dow gained 1.24%.
McKesson finished 25.56% below its 52-week high of $999 reached on 3 March, as Amazon rose 0.53%, UnitedHealth added 0.94% and CVS jumped 7.65%.
Trading volume reached 2.9 million shares, far above McKesson's 50-day average of 774,347, indicating unusually heavy selling despite a broadly positive market session.
Is Wall Street ignoring clear warning signs as McKesson's stock plummets before its crucial earnings report?
Will the billion-dollar boom in weight-loss drugs save McKesson or expose its biggest vulnerabilities?
As Mideast conflict cripples global shipping, are America's medicine cabinets about to run empty?